IMMU-14. ONCOLYTIC ADENOVIRUS DELTA-24-RGD ENGINEERED TO EXPRESS 4-1BBL AS A THERAPEUTIC APPROACH FOR DIPG

Despite the advances in our understanding of pediatric diffuse midline gliomas (DMG) they remain the leading cause of pediatric death caused by cancer. Our group has demonstrated that the administration of Delta-24-RGD in DIPG models is safe and therapeutically efficacious. An on-going clinical tria...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Laspidea, Virginia, Puigdelloses, Montserrat, Martinez-Velez, Naiara, Garcia-Moure, Marc, Labiano, Sara, Ausejo, Iker, Patiño-García, Ana, Becher, Oren J, Jiang, Hong, Gupta, Sumit, Fueyo, Juan, Gomez-Manzano, Candelaria, M Alonso, Marta
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651280/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.444
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi